Robert Bosch Krankenhaus (Stuttgart) - Start of a new trial site

Today, the Robert Bosch Hopsital in Stuttgart became officially an active trial site of the STOP-PKD Study.

The team of Prof. Jörg Latus cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Stuttgart to obtain detailed information about the trial and potential participation.

Phone: 0711-81015874

Email:  andrea.schwab@rbk.de